Effects of Adopting Preventive Drug Lists on Medication Costs and Disparities by Income Over 2 Years: A Natural Experiment for Translation in Diabetes (NEXT-D) Study
PDLs offer an effective strategy for employers and insurers to lower member cost sharing and encourage increased use of important medications to prevent or manage chronic illnesses. For patients with diabetes, especially those with lower incomes, PDL coverage resulted in substantial and persistent reductions in out-of-pocket medication costs, medication use increases, and some increased use of more expensive products.
Authors
- Stephanie Argetsinger
- Matthew Lakoma
- Christine Y. Lu (ORCID: https://orcid.org/0000-0002-7550-6837)
- Dennis Ross‐Degnan (ORCID: https://orcid.org/0000-0002-0066-1242)
- Fang Zhang (ORCID: https://orcid.org/0000-0002-7000-554X)
Institutions
- The University of Sydney (AU)
- Harvard University (US)
- Duke University (US)
- Harvard Pilgrim Health Care (US)
- Northern Sydney Local Health District (AU)
Publication Details
- Journal
- Diabetes Care
- Published
- 2024-10-08
- DOI
- https://doi.org/10.2337/dc24-0361
- Citations
- 4
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 4.52
Funders
- Centers for Disease Control and Prevention
- National Institute of Diabetes and Digestive and Kidney Diseases